Abstract
Human papillomaviruses (HPVs) cause superficial epidermal infections and are only cleared if they trigger an immunological response. We analysed SNPs that had previously been investigated for association with HPV infection to determine whether they play a role in the serological response to cutaneous beta-HPVs in an Australian population. Serum samples from 1,142 participants were analysed for seropositivity against the L1 protein of 21 beta-HPV types. Associations between seropositivity to beta-HPV types and the SNPs rs9264942 (HLA-C; HPV-9, p = 0.022, HPV-15, p = 0.043 and HPV-17, p = 0.004), rs12449858 (EVER1; HPV-23, p = 0.029), and rs2981451 (FGFR2; HPV-22, p = 0.049) were identified. We found that certain SNPs could be involved in the serological response to beta-HPVs.
Availability of data and material
Available upon request from authors.
Code availability
Available upon request from authors.
References
Andersson K, Waterboer T, Kirnbauer R, Slupetzky K, Iftner T, de Villiers EM, Forslund O, Pawlita M, Dillner J (2008) Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions. Cancer Epidemiol Biomark Prev 17:189–195
Antonsson A, Forslund O, Ekberg H, Sterner G, Hansson BG (2000) The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol 74:11636–11641
Antonsson A, Green AC, Mallitt KA, O’Rourke PK, Pandeya N, Pawlita M, Waterboer T, Neale RE (2010) Prevalence and stability of antibodies to 37 human papillomavirus types—a population-based longitudinal study. Virology 407:26–32
Antonsson A, Law MH, Neale RE, Coman WB, Pryor DI, Porceddu SV, Whiteman DC, Study of Digestive H (2016) Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck. Cancer Causes Control 27:809–815
Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401:70–79
Boxman IL, Russell A, Mulder LH, Bavinck JN, Schegget JT, Green A (2000) Case-control study in a subtropical Australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus DNA in plucked eyebrow hairs. The Nambour Skin Cancer Prevention Study Group. Int J Cancer 86:118–121
Bzhalava D, Eklund C, Dillner J (2015) International standardization and classification of human papillomavirus types. Virology 476:341–344
Castro FA, Ivansson EL, Schmitt M, Juko-Pecirep I, Kjellberg L, Hildesheim A, Gyllensten UB, Pawlita M (2012) Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility. Int J Cancer 130:349–355
Chen D, McKay JD, Clifford G, Gaborieau V, Chabrier A, Waterboer T, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Bencko V, Janout V, Foretova L, Mates IN, Szeszenia-Dabrowska N, Curado MP, Koifman S, Menezes A, Wunsch-Filho V, Eluf-Neto J, Fernandez Garrote L, Matos E, Zelenika D, Boland A, Boffetta P, Pawlita M, Lathrop M, Brennan P (2011) Genome-wide association study of HPV seropositivity. Hum Mol Genet 20:4714–4723
de Villiers EM, Ruhland A (2001) Do specific human papillomavirus types cause psoriasis? Arch Dermatol 137:384
Favre M, Orth G, Majewski S, Baloul S, Pura A, Jablonska S (1998) Psoriasis: a possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J Invest Dermatol 110:311–317
Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, Zhang K, Gumbs C, Castagna A, Cossarizza A, Cozzi-Lepri A, De Luca A, Easterbrook P, Francioli P, Mallal S, Martinez-Picado J, Miro JM, Obel N, Smith JP, Wyniger J, Descombes P, Antonarakis SE, Letvin NL, McMichael AJ, Haynes BF, Telenti A, Goldstein DB (2007) A whole-genome association study of major determinants for host control of HIV-1. Science 317:944–947
Green A, Williams G, Neale R, Hart V, Leslie D, Parsons P, Marks GC, Gaffney P, Battistutta D, Frost C, Lang C, Russell A (1999) Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 354:723–729
Kulkarni S, Savan R, Qi Y, Gao X, Yuki Y, Bass SE, Martin MP, Hunt P, Deeks SG, Telenti A, Pereyra F, Goldstein D, Wolinsky S, Walker B, Young HA, Carrington M (2011) Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 472:495–498
Lazarczyk M, Pons C, Mendoza JA, Cassonnet P, Jacob Y, Favre M (2008) Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med 205:35–42
Majewski S, Favre M, Orth G, Jablonska S (1998) Is human papillomavirus type 5 the putative autoantigen involved in psoriasis? J Invest Dermatol 111:541–542
Paradisi A, Waterboer T, Sampogna F, Tabolli S, Simoni S, Pawlita ML, Abeni D (2011) Seropositivity for human papillomavirus and incidence of subsequent squamous cell and basal cell carcinomas of the skin in patients with a previous non-melanoma skin cancer. Br J Dermatol 165:782–791
Sehr P, Zumbach K, Pawlita M (2001) A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J Immunol Methods 253:153–162
Thoens C, Heinold A, Lindemann M, Horn PA, Chang DI, Scherbaum N, Timm J, Heinemann FM (2018) A Single-nucleotide polymorphism upstream of the HLA-C locus is associated with an anti-hepatitis C virus-seronegative state in a high-risk exposed cohort. J Infect Dis 218:2016–2019
Vineretsky KA, Karagas MR, Kuriger-Laber JK, Waterboer T, Pawlita M, Nelson HH (2014) HLA-C -35kb expression SNP is associated with differential control of beta-HPV infection in squamous cell carcinoma cases and controls. PLoS ONE 9:e103710
Wang SS, Gonzalez P, Yu K, Porras C, Li Q, Safaeian M, Rodriguez AC, Sherman ME, Bratti C, Schiffman M, Wacholder S, Burk RD, Herrero R, Chanock SJ, Hildesheim A (2010) Common genetic variants and risk for HPV persistence and progression to cervical cancer. PLoS ONE 5:e8667
Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO, Templin MF, Pawlita M (2005) Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem 51:1845–1853
Youssefian L, Vahidnezhad H, Mahmoudi H, Saeidian AH, Daneshpazhooh M, Kamyab Hesari K, Zeinali S, de Jong SJ, Orth G, Blanchet-Bardon C, Jouanguy E, Casanova JL, Uitto J (2019) Epidermodysplasia verruciformis: genetic heterogeneity and EVER1 and EVER2 mutations revealed by genome-wide analysis. J Invest Dermatol 139:241–244
Zhong S, Jiang D, McPeek MS (2016) CERAMIC: case-control association testing in samples with related individuals, based on retrospective mixed model analysis with adjustment for covariates. PLoS Genet 12:e1006329
Zou J, Cao Z, Zhang J, Chen T, Yang S, Huang Y, Hong D, Li Y, Chen X, Wang X, Cheng X, Lu W, Xie X (2016) Variants in human papillomavirus receptor and associated genes are associated with type-specific HPV infection and lesion progression of the cervix. Oncotarget 7:40135–40147
Acknowledgements
We would like to thank all participants of the Nambour Skin Cancer Study. We thank Prof Lyn Griffiths, Ms Rebecca Grealy, and Griffith University for their invaluable contributions to the Nambour Skin Cancer Study DNA resource, including sharing sample processing and storage. We are also grateful to Profs Nick Martin and David Whiteman for their support.
Funding
This work was supported by a Program Grant (1073898) from the National Health and Medical Research Council of Australia (NHMRC). The funding body played no role in the design or conduct of the study. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the funding body.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Annika Antonsson, Astrid J. Rodriguez-Acevedo, Maria Celia B. Hughes, and Adele C. Green. The first draft of the manuscript was written by Annika Antonsson, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Ethics approval
QIMR Berghofer Medical Research Institute’s Human Research Ethics Committee (P327).
Additional information
Handling Editor: Carolina Scagnolari.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Antonsson, A., Rodriguez-Acevedo, A.J., Liyanage, U.E. et al. Host genetic polymorphisms associated with beta human papillomavirus seropositivity. Arch Virol 166, 2569–2572 (2021). https://doi.org/10.1007/s00705-021-05137-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-021-05137-4